Notably, a case–control study in China demonstrated that HBV infection was potentially an independent risk factor regardless of other factors in middle-aged breast cancer development (103), as the positive rate of HBc antibody (HBcAb) in patients with breast cancer (66.4%) was significantly higher than that in the controls (53.7%). Here, KRT88P is linked to breast carcinoma.